发明名称 |
COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS |
摘要 |
Modulation of the complement system represents a therapeutic modality for numerous pathologic conditions associated with complement activation. In a strategy to prepare complement inhibitors that are targeted to sites of complement activation and disease, compositions comprising a complement inhibitor linked to complement receptor (CR) 2 are disclosed. The disclosed are compositions can be used in methods of treating pathogenic diseases and inflammatory conditions by modulating the complement system. |
申请公布号 |
US2012015872(A1) |
申请公布日期 |
2012.01.19 |
申请号 |
US201113162434 |
申请日期 |
2011.06.16 |
申请人 |
TOMLINSON STEPHEN;HOLERS V. MICHAEL;THE REGENTS OF THE UNIVERSITY OF COLORADO;MUSC FOUNDATION FOR RESEARCH DEVELOPMENT |
发明人 |
TOMLINSON STEPHEN;HOLERS V. MICHAEL |
分类号 |
A61K38/16;A61K38/00;A61K39/00;A61K39/395;A61P31/04;A61P31/10;A61P31/12;A61P33/00;C07K14/00;C07K14/435;C07K14/705;C07K16/28 |
主分类号 |
A61K38/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|